Form 8-K · Current Report · Filed 2025-03-10
Cardinal Health Elects New Independent Directors to Board
On March 7, 2025, Cardinal Health, Inc. announced the election of Robert W. Musslewhite, former CEO of Definitive Healthcare Corp., and Sudhakar Ramakrishna, CEO of SolarWinds Corporation, as independent directors to its Board. Both appointees bring extensive leadership experience in technology and healthcare. Musslewhite will serve on the Audit and Human Resources and Compensation Committees, while Ramakrishna will serve on the Audit and Risk Oversight Committees. This news was disclosed under Regulation FD on March 10, 2025.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0000721371-25-000020
- CIK
- 0000721371
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$126.50
Next session
-1.8%
Since filing
+81.8%
Latest close
$230.03
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
Exhibits (1)
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.